Search for Clinical Trial Results

Sponsored By

Chromosome Deletion - 16 Studies Found

Status Study
Active, not recruiting Study Name: Aneuploidies in Embryos and Spermatozoa From Patients With Y-chromosome Microdeletions
Condition: Male Sterility Due to Y-chromosome Deletions
Date: 2015-08-11
Terminated Study Name: A Dose Range Finding Study of Lenalidomide in Non-5q Chromosome Deletion in Low and Intermediate Risk Myelodysplastic Syndrome (MDS) Patients
Condition:
  • Myelodysplastic Syndrome
  • MDS
  • Low to Intermediate-1 MDS Date: 2008-06-13
    Interventions: Drug: Lenalidomide Dose Level Lenalidomide Schedule
Completed Study Name: Mitochondrial Dysfunction in Phelan-McDermid Syndrome: Explaining Clinical Variation and Providing a Path Towards Treatment
Condition: Phelan-McDermid Syndrome
Date: 2013-11-25
Recruiting Study Name: Treatment Strategies for Children With Smith-Magenis Syndrome
Condition:
  • Developmental Delay Disorders
  • Chromosome Deletion
  • Date: 2007-07-21
    Interventions:
    • Drug: dTR Melatonin (NIH CC PDS)
    • Device: P
Recruiting Study Name: Expanded Noninvasive Genomic Medical Assessment: The Enigma Study
Condition:
  • Down Syndrome
  • Edwards Syndrome
  • Patau Syndrome
  • Date: 2016-05-26
    Interventions: Other: Blood sampling for Laboratory Developed Test (LDT) analysis Each enrolled subject, either in the
Recruiting Study Name: Piloting Treatment With Intranasal Oxytocin in Phelan-McDermid Syndrome
Condition: Phelan-McDermid Syndrome
Date: 2016-03-07
Interventions:
  • Drug: Oxytocin Intranasal oxyt
Completed Study Name: Clinical Trial in 22q13 Deletion Syndrome(Phelan-McDermid Syndrome)
Condition:
  • 22q13 Deletion Syndrome
  • Phelan-McDermid Syndrome

Date: 2012-02-01
Interventions:
  • Drug: Insulin-Like Growth Factor-1 (IGF-1)

Completed Study Name: Study of the Pathophysiological Mechanisms Involved in Bleeding Events
Condition: Oculocerebrorenal Syndrome
Date: 2011-03-11
Interventions: Other: Blood sample Blood sample
Enrolling by invitation Study Name: Sulfamethoxazole for the Treatment of Primary PREPL Deficiency
Condition:
  • Hypotonia Cystinuria Syndrome
  • Isolated PREPL Deficiency

Date: 2015-10-07
Interventions: Drug: Sulfamethoxazole 60 mg sulfamethoxazole per kg bodyweight (maximal of 3g) divided in 2 doses per d
Active, not recruiting Study Name: RA-2 13-cis Retinoic Acid (Isotretinoin)
Condition:
  • Male Infertility
  • Klinefelter's Syndrome
  • Y-chromosome Micro
    Date: 2014-02-10
    Interventions:
    • Drug: 13-cis retinoic acid Acc
Next >>>